These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10655006)

  • 1. Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
    Olfson M; Mechanic D; Hansell S; Boyer CA; Walkup J; Weiden PJ
    Psychiatr Serv; 2000 Feb; 51(2):216-22. PubMed ID: 10655006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication noncompliance and substance abuse among patients with schizophrenia.
    Owen RR; Fischer EP; Booth BM; Cuffel BJ
    Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of relapse in schizophrenia.
    Weiden PJ; Olfson M
    Schizophr Bull; 1995; 21(3):419-29. PubMed ID: 7481573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
    Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
    Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia.
    Rosa MA; Marcolin MA; Elkis H
    Braz J Psychiatry; 2005 Sep; 27(3):178-84. PubMed ID: 16224604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia.
    Valenstein M; Copeland LA; Owen R; Blow FC; Visnic S
    J Clin Psychiatry; 2001 Jul; 62(7):545-51. PubMed ID: 11488366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication compliance in patients with chronic schizophrenia: implications for the community management of mentally disordered offenders.
    Duncan JC; Rogers R
    J Forensic Sci; 1998 Nov; 43(6):1133-7. PubMed ID: 9846389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
    Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
    Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating compliance with antipsychotic medication.
    Marder SR
    J Clin Psychiatry; 1998; 59 Suppl 3():21-5. PubMed ID: 9541334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication noncompliance in adolescents with psychiatric disorders.
    Ghaziuddin N; King CA; Hovey JD; Zaccagnini J; Ghaziuddin M
    Child Psychiatry Hum Dev; 1999; 30(2):103-10. PubMed ID: 10668306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.
    Lacro JP; Dunn LB; Dolder CR; Leckband SG; Jeste DV
    J Clin Psychiatry; 2002 Oct; 63(10):892-909. PubMed ID: 12416599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study.
    Yamada K; Watanabe K; Nemoto N; Fujita H; Chikaraishi C; Yamauchi K; Yagi G; Asai M; Kanba S
    Psychiatry Res; 2006 Jan; 141(1):61-9. PubMed ID: 16318875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking inpatients with schizophrenia to outpatient care.
    Olfson M; Mechanic D; Boyer CA; Hansell S
    Psychiatr Serv; 1998 Jul; 49(7):911-7. PubMed ID: 9661225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of relapse in the year after hospital discharge among patients with schizophrenia.
    Schennach R; Obermeier M; Meyer S; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    Psychiatr Serv; 2012 Jan; 63(1):87-90. PubMed ID: 22227766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and treatment selection for "revolving door" inpatients with schizophrenia.
    Weiden P; Glazer W
    Psychiatr Q; 1997; 68(4):377-92. PubMed ID: 9355136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of medication compliance after hospital discharge in adolescent psychiatric patients.
    Lloyd A; Horan W; Borgaro SR; Stokes JM; Pogge DL; Harvey PD
    J Child Adolesc Psychopharmacol; 1998; 8(2):133-41. PubMed ID: 9730079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of partial compliance.
    Marder SR
    J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.